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Background
Signs of nervous system dysfunction such as headache or convulsions 
often occur in severe systemic hypertension. Less recognized is the 
association between severe hypertension and peripheral facial nerve 
palsy. The aim of this study was to systematically review the literature 
on the association of peripheral facial palsy with severe hypertension.
METHodS
Systematic review of Medline, Embase, Web of Science, and Google 
Scholar from 1960 through December 2011 and report of two cases.
rESuLTS
The literature review revealed 24 cases to which we add two cases with 
severe hypertension and peripheral facial palsy. Twenty-three patients 
were children. Palsy was unilateral in 25 cases, bilateral in one case, and 
recurred in nine. The time between the first facial symptoms and diag-
nosis of hypertension was a median of 45 days (range, 0 days–2 years). 
In five case series addressing the complications of severe hypertension 
in children, 41 further cases of peripheral facial palsy were listed out of 
860 patients (4.8%).
concLuSionS
The association between severe hypertension and peripheral facial 
palsy is mainly described in children. Arterial hypertension is diagnosed 
with a substantial delay. Outcome is favorable with adequate antihy-
pertensive treatment. The pathophysiology is still debated.
Keywords: arterial hypertension; blood pressure; children; hypertension; 
hypertensive emergency; peripheral facial paralysis; systematic review.
doi:10.1093/ajh/hps045
Peripheral facial nerve palsy typically presents with weak-
ness of all muscles of the face: The facial creases and nasola-
bial fold disappear, the forehead unfurrows, and the corner 
of the mouth droops. In more severe cases, the eyelid does 
not close and on attempted closure the Bell’s phenomenon 
with the eye rolling upward becomes noticeable. Acute 
peripheral facial nerve palsy may result from infectious 
conditions such as Lyme disease, otitis media, chickenpox, 
herpes zoster oticus, mumps, and mononucleosis; from 
noninfectious, presumably inflammatory disorders such as 
the Melkersson-Rosenthal syndrome; and from traumas or 
neoplasms. However most cases present without an appar-
ent cause and are classified as Bell’s palsy.1 There is also an 
association between peripheral facial nerve palsy and severe 
systemic hypertension, as was first described by Moxon 
more than a century ago.2–3 We systematically review the lit-
erature on this entity and report on two children in whom 
facial nerve palsy led to the detection of severe systemic 
hypertension.
METHodS
The US National Library of Medicine, Embase, Web of 
Science, and the web-based search engine Google Scholar 
were searched using the terms arterial hypertension, sys-
temic hypertension, and malignant hypertension, each com-
bined with peripheral facial nerve paralysis and Bell paralysis, 
limiting the search to publications in English, German, and 
Italian dating from January 1960 to December 2011. If the 
publication was available as a full-length article or a letter, 
if the patients included were individually described reveal-
ing at least age, sex, and blood pressure (BP) measurement 
in the hypertensive range; if the facial palsy was specified as 
being of the peripheral type, the publication was included in 
this study. From each case of severe systemic hypertension 
complicated by peripheral facial nerve palsy, two authors 
(R.J.  and G.P.M.) independently excerpted the patients’ 
clinical characteristics including information on the under-
lying cause of systemic hypertension, family and previous 
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personal history, further investigations performed, such as 
neuroimaging, treatment modalities applied, and critically 
appraised the publications.
The time to diagnosis was defined as the time elapsed 
between the first facial symptoms and the diagnosis of arte-
rial hypertension. Severe hypertension was defined as a BP 
exceeding the 99th percentile by >5 mm Hg in children or 
180/110 mm Hg in adults.4 For each patient the extent of 
severe hypertension was expressed by means of the modified 
BP severity index, which is calculated dividing the measured 
BP (in mm Hg) by either the calculated 99th percentile BP 
value specific for that patient plus 5 mm Hg in children or by 
180/110 mm Hg in adults. The facial nerve dysfunction was 
graded as mild in subjects with preserved eye closure and 
severe in those with impaired eye closure.
Written informed consent for publication of information 
regarding the two described cases was obtained from both 
patients’ parents.
Continuous data are presented as median values with 
interquartile range (IQR) or minimum and maximum range, 
and categorical data as frequencies and percentages calcu-
lated from the results reported in the original publications. 
Correlation analyses were performed with the Spearman 
test. Comparison of prevalence between the groups was per-
formed using the Fisher exact test. All the statistical analy-
ses were performed with GraphPad Prism, version 4.01 for 
Windows (GraphPad Software, San Diego, CA).
rESuLTS
Systematic review of the literature
The systematic review revealed 326 publications, of 
which 282 remained after excluding duplicates. Fifteen pub-
lications met the inclusion criteria. The references of these 
15 reports revealed three further publications meeting the 
inclusion criteria. In total, 18 reports were included in this 
study (17 in English, one in Italian) describing 24 cases.5–22 
All publications included were reports of single cases or 
case series.
Finally, we found 41 additional cases of peripheral facial 
nerve palsy in five publications which specifically addressed 
the neurological signs of severe systemic hypertension in pedi-
atric patients. These cases were only listed and not described 
in detail, permitting only analysis of prevalence.14, 23–26
case reports
Case 1. A previously healthy 5-year-old boy developed 
left facial muscular weakness, which spontaneously recov-
ered over two months. At this time BP was not measured. 
Three months later he was referred because of headache, 
nocturia, and a similar facial weakness on the same side. 
The physical examination disclosed left-sided peripheral 
facial nerve paresis with normal facial symmetry and tone 
at rest, four-limb BP of 220/160 mm Hg, and bilateral retinal 
hemorrhages and tortuous vessels on fundoscopy. Urinalysis 
disclosed pathological proteinuria (++) and mild erythrocy-
turia. Electrocardiography and echocardiography revealed 
left ventricular hypertrophy. Blood investigations showed a 
normal complete blood cell count and renal profile, a nor-
mal circulating complement C3 level, and absent antinuclear 
and antineutrophil autoantibodies. The final diagnosis of 
segmental renal hypoplasia with systemic hypertension was 
made by means of renal ultrasound and, subsequently, con-
trast-enhanced abdominal computed tomography, which 
revealed a segmental cortical thinning and dilated calices 
in the upper part of the right kidney. A  voiding cystoure-
thrography failed to detect a vesicoureteral reflux. The BP 
was gradually brought under control, initially with intrave-
nous labetolol, later on medication with ramipril and chlor-
talidon. After 2 weeks, BP values were slightly below the 95th 
percentile (108/69 mm Hg). The facial nerve paresis resolved 
after BP was brought under control and completely within 
2 months. One year later, BP remained within normal range 
and further neurological complications were not observed.
Case  2. In a previously healthy 11-year-old girl with 
sudden onset of left facial weakness and negative serologic 
testing for Lyme disease, the suspected diagnosis of idi-
opathic peripheral facial nerve paresis was made and oral 
prednisone (1 mg per kg body weight per day for 7  days) 
prescribed. At this time BP was not measured. Ten days later 
the girl experienced a generalized tonic-clonic seizure and 
was admitted to hospital. Physical examination revealed a 
left-sided peripheral facial nerve paresis (with normal facial 
symmetry and tone at rest), four-limb BP of 230/170 mm 
Hg, bilateral retinal hemorrhages and tortuous vessels on 
fundoscopy, and an epigastric systolic bruit. Urinalysis dis-
closed pathological proteinuria (+/++) and erythrocyturia. 
Electrocardiography and echocardiography revealed a left 
ventricular hypertrophy. Blood investigations showed a 
normal complete blood cell count and renal profile, and a 
negative autoimmune profile. The BP was gradually brought 
under better control (after 1 week BP was 123/84 mm Hg), 
initially with intravenous labetolol, later on combined medi-
cation with amlodipine and chlortalidon. Renal angiography 
disclosed a proximal left renal artery stenosis secondary to 
a fibromuscular dysplasia that was successfully treated by 
angioplasty. The facial nerve paresis resolved within 6 weeks, 
after having brought BP under control (at that time BP was 
115/74 mm Hg). On follow-up, after 6  months, antihyper-
tensive treatment could be tapered off and BP remained 
within the normal range 1 year later.
analysis of all cases
Demographics. Of the 24 patients reported in the litera-
ture and the presented two cases with severe systemic hyper-
tension complicated by peripheral facial nerve palsy, 16 
were female, 10 male. Median age was 9.5 years (IQR, 2.5–
12 years; range, 11 weeks–62 years). Twenty-three patients 
(88%) were children 15  years of age or younger (Table  1, 
Figure 1). The mean modified severity index of arterial BP 
was 1.67 (IQR, 1.39–1.73)/1.58 (IQR, 1.36–1.84).
Characteristics of peripheral facial palsy. At presentation 
the facial palsy was unilateral in 25 cases (left-sided, n = 14; 
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right-sided, n = 11) and bilateral in one case. Recurrence of 
peripheral facial palsy was reported in nine patients, occur-
ring ipsilaterally in five6–7,17,22 and contralaterally in another 
four.9–10,12,18 Facial nerve dysfunction was mild in four and 
severe in eight patients (no information on grading of the 
peripheral facial palsy is available for the remaining cases). 
No correlation was found in these patients between severity 
of facial palsy and the modified BP severity index.
Concomitant signs and symptoms. Additional signs of 
nervous system dysfunction were described in 16 patients, 
consisting of headache (n = 7), vomiting (n = 5), convulsions 
(n = 4), hyperactive reflexes (n = 2), positive Babinski sign 
(n  =  1), altered level of consciousness (n  =  3), visual field 
defect (n = 1), internuclear ophthalmoplegia (n = 1), and not 
further described transient double vision (n = 1), as depicted 
in Table 1. In three patients, peripheral facial nerve palsy and 
severe systemic hypertension were associated with Guillain-
Barré syndrome.11,19
Diagnosis of arterial hypertension. The time elapsed 
between the first facial symptoms and the diagnosis of severe 
systemic hypertension lasted a median of 45  days (range, 
0 days–2 years) in 16 cases in which this information was 
provided. In nine patients, BP was not recorded initially and 
the preliminary diagnosis of idiopathic facial nerve palsy 
made, although in six of these patients additional neuro-
logical signs and symptoms were present.6-7,9-10,17-18,21-22 Both 
systolic and diastolic severe hypertension were disclosed in 
24 and severe systolic hypertension in the remaining two 
patients (Table  1). In the three adult patients, facial palsy 
was found some years after the diagnosis of arterial hyper-
tension. In these cases, facial palsy occurred when BP was 
not well controlled (nonadherence of antihypertensive treat-
ment) and severe hypertension exacerbated.5,8,12 The eti-
ology of arterial hypertension was established in 19 patients, 
consisting of congenital anomalies of the kidney and urinary 
tract,6,17,20–21 aortic coarctation,13,15–16 renal artery stenosis,8,18 
renal adenocarcinoma,10 and pheochromocytoma7(Table 1). 
In the three children with Guillain-Barré syndrome,11,19 both 
isolated peripheral facial nerve palsy and severe systemic 
hypertension were the presenting signs before further fea-
tures of the polyneuropathy were apparent. The cause of 
arterial hypertension remained unknown or classified as pri-
mary hypertension in seven patients.5,9,12,14,17,21–22
Site of the  lesion. Neuroimaging was described in 11 
patients, nine of whom were children (Table 1).5–6,8–9,15,17–20 
Computed tomography was performed in two and mag-
netic resonance imaging (MRI) in nine patients. Cerebral 
MRI revealed a pontine hemorrhage at the site of the 
facial nucleus in a 9-year-old girl,6 and an ischemic stroke 
in the dorsal pons affecting the post-nuclear facial fibers 
in a 47-year-old man.5 Four patients had signs of multiple 
ischemic infarcts in the periventricular white matter; three 
showed involvement of the thalamus and the basal ganglia, 
one had additional lesions in the insular and occipital cor-
tex.8–9,17–18 In two patients with Guillain-Barré syndrome 
and gadolinium enhancement of spinal nerve roots on MRI, 
no cerebral or cranial nerve abnormalities were described.19 
In three patients, one of whom had a computed tomography, 
neuroimaging was normal (Table 1).15,20
No electrophysiological findings specifically addressing 
the facial nerve were reported.
An edematous nerve sheath with vessel engorgement 
without hemorrhage was revealed in the child who under-
went decompression of the facial nerve from the cochleari-
form process to the stylomastoid foramen.21
Therapeutic approaches and outcome. In 23 patients, 
BP reduction after correction of the underlying disorder or 
antihypertensive drug management was followed by a grad-
ual resolution of the facial nerve palsy (19 complete and four 
partial resolutions, median time to resolution was 2 [IQR, 
0.9–6] months; Table 1). In an 8-month-old girl facial nerve 
palsy resolved following surgical removal of a nonfunction-
ing kidney, medical stabilization of BP and surgical decom-
pression of the facial nerve.21 The child with persisting facial 
nerve palsy reported by Bialestock in 1961 died because of 
very severe, refractory hypertension.7
Steroids were prescribed in three cases reported in the lit-
erature and in our case II.6,17–18 All four of these patients were 
children in whom BP had not been measured at initial diagno-
sis of peripheral facial nerve palsy, which had been interpreted 
as Bell’s palsy and subsequently treated with corticosteroids. 
No information on dosage and duration of steroid treatment 
was available in the three patients found in the literature.
Peripheral facial nerve palsy in publications dealing  
with nervous system involvement in the context  
of severe hypertension
Forty-one cases of peripheral facial nerve palsy were 
found in five publications which specifically addressed the 
neurological signs of systemic hypertension in a total of 
860 severely hypertensive children (4.8%, Table  2).14,23–26 
Headache was by far the most common neurological com-
plication in children with severe arterial hypertension, fol-
lowed in decreasing order by altered level of consciousness 
and vomiting, convulsions, focal central nervous system 
deficit, and peripheral facial nerve palsy.
Figure 1. Age distribution of the 26 patients with severe hypertension 
and peripheral facial nerve palsy. No significant difference was noted in 
the gender distribution between the age groups (Fisher exact test).
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diScuSSion
The main finding of this study is the fact that peripheral 
facial nerve palsy associated with severe arterial hyperten-
sion is primarily described in children and adolescents. 
The long time to diagnosis of arterial hypertension, lasting 
a median of 45  days, indicates that this association is not 
widely recognized. Particularly in children, BP measure-
ment is not firmly considered as a critical component of 
the routine physical examination. However, recent clinical 
reviews addressing the management of peripheral facial 
palsy in childhood mention severe systemic hypertension 
as a specific cause.1, 27 Within the group of severely hyper-
tensive children and adolescents, peripheral facial palsy was 
described in 4.8% (41/860) ranging from 2.8% to 20% as 
indicated in five publications dealing with the complications 
of severe childhood hypertension.14, 23–26 Moreover, in a sur-
vey dealing with the different etiologies of peripheral facial 
nerve palsy, arterial hypertension was the cause in 7 of 87 
(8%) children.14
Lower motor neuron facial palsy has previously been 
associated with the hypertensive disorders of pregnancy and 
puerperium,28 and a recent case-control study suggests that 
chronic, nonsevere hypertension may increase the risk of 
lower motor neuron facial nerve palsy in subjects older than 
40 years of age.29
A timely diagnosis of arterial hypertension in the case 
of peripheral facial palsy is crucial in order to start ade-
quate antihypertensive treatment. The majority of the cases 
showed full recovery of the facial palsy some weeks after 
onset of treatment. It remains unclear whether medication 
directly affects speed and degree of resolution or acts only to 
prevent further recurrence, since some cases demonstrated 
spontaneous resolution prior to the diagnosis of arterial 
hypertension. In the three adult cases with known chronic 
arterial hypertension, facial palsy occurred during exacerba-
tion of severe arterial hypertension due to nonadherence of 
medication and immediately resolved after better BP con-
trol, suggesting a direct relationship between BP lowering 
and resolution of facial palsy.5,8,12 Corticosteroids, the stand-
ard treatment of Bell’s palsy, potentially exacerbate arterial 
hypertension and are therefore not indicated.
The putative mechanisms underlying the dysfunction of 
the facial nerve or its nucleus were addressed in a minority 
of the affected patients. These include a swelling of the facial 
nerve in its bony canal associated with vessel engorgement, a 
hemorrhage into the facial canal, as reported in two necrop-
sies,3, 30 an ischemic stroke affecting the postnuclear fibers 
of the nerve, or a bleeding in the facial nerve nucleus. These 
mechanisms may be implicated also in the development of 
facial palsy during preeclampsia.28
Both lower motor neuron facial nerve palsy and arterial 
hypertension have independently been described as features 
of Guillain-Barré syndrome.31 Whether the cases of facial 
nerve palsy reported in three children with Guillain-Barré 
syndrome included in this analysis were caused by severe 
hypertension or were a first manifestation of the polyneu-
ropathy remains uncertain.
The most important limitation of this review lies in the 
small number of reported patients affected by peripheral 
facial nerve palsy caused by severe systemic hypertension 
and the retrospective nature of the analysis. A second limita-
tion is that adequate neuroimaging studies were rarely per-
formed. Finally, the degree of facial palsy was not assessed 
using a facial nerve grading system.
In conclusion, this review provides evidence that there 
might be an association of uncontrolled hypertension and 
facial palsy that warrants additional evaluation. With effect-
ive acute and chronic antihypertensive therapy, the progno-
sis of facial palsy is excellent. A gradual normalization of BP 
in 2–3 days is advised.4,32–33
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